Cibus (CBUS) Other Working Capital Changes (2016 - 2025)
Cibus (CBUS) posted Other Working Capital Changes of -$17000.0 for Q4 2025, down 325.0% sequentially from -$4000.0 in Q3 2025, and up 73.02% YoY from -$9825.7 in Q4 2024.
Cibus (CBUS) Other Working Capital Changes (2016 - 2025) Analysis & Trends
Cibus has reported Other Working Capital Changes for 6 years, with the latest figure at -$17000.0 in Q4 2025.
- Quarterly Other Working Capital Changes rose 73.02% year-over-year to -$17000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $28000.0 (down 86.85% YoY) and the FY2025 annual result came in at $28000.0, down 86.85% from the prior year.
- Other Working Capital Changes slipped to -$17000.0 in Q4 2025 per CBUS's latest filing, from -$4000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $461000.0 in Q2 2024 and troughed at -$2.7 million in Q2 2021.
- A 5-year average of -$318550.0 and a median of -$203500.0 in 2022 frame the typical range for Other Working Capital Changes.
- The widest YoY moves for Other Working Capital Changes: up 1135.96% in 2021, down 3220.63% in 2021.
- Over 5 years, Other Working Capital Changes stood at -$37000.0 in 2021, then plunged by 1456.76% to -$576000.0 in 2022, then soared by 44.62% to -$319000.0 in 2023, then surged by 80.25% to -$63000.0 in 2024, then surged by 73.02% to -$17000.0 in 2025.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$17000.0, -$4000.0, and $113000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Cibus | 129.72 Mn | 109.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -324,000.00 |
| Dec 31, 2025 | -324,000.00 |
| Dec 31, 2025 | -324,000.00 |
| Sep 30, 2025 | -703,000.00 |
| Sep 30, 2025 | -703,000.00 |
| Sep 30, 2025 | -703,000.00 |
| Jun 30, 2025 | 353,000.00 |
| Jun 30, 2025 | 353,000.00 |
| Jun 30, 2025 | 353,000.00 |
| Mar 31, 2025 | -309,000.00 |
| Mar 31, 2025 | -309,000.00 |
| Mar 31, 2025 | -309,000.00 |
| Dec 31, 2024 | -106,000.00 |
| Dec 31, 2024 | -106,000.00 |
| Dec 31, 2024 | -106,000.00 |
| Sep 30, 2024 | -442,000.00 |
| Sep 30, 2024 | -442,000.00 |
| Sep 30, 2024 | -442,000.00 |
| Jun 30, 2024 | 461,000.00 |
| Jun 30, 2024 | 461,000.00 |